Results
1 -
10 of
96María Vallet-Regí, Miguel Manzano, José M. González-Calbet and Eiji Okunishi.
Evidence of drug confinement into silica mesoporous matrices by STEM spherical aberration corrected microscopy, Chem. Commun., 2010, 46, 2956. Laurence Motte, Farah Benyettou, Caroline de Beaucorps, Marc Lecouvey, Irena Milesovic and Yoann Lalatonne.
Multimodal superparamagnetic nanoplatform for clinical applications: immunoassays, imaging & therapy, Faraday Discuss., 2011, 149, 211. Hélène Roussière, Gilles Montavon, Samia Laïb, Pascal Janvier, Bruno Alonso, Franck Fayon, Marc Petit, Dominique Massiot, Jean-Michel Bouler and Bruno Bujoli.
Hybrid materials applied to biotechnologies: coating of calcium phosphates for the design of implants active against bone resorption disorders, J. Mater. Chem., 2005, 15, 3869. Zoledronic acid induces apoptosis via stimulating the expressions of ERN1, TLR2, and IRF5 genes in glioma cells, Tumor Biology Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway, Tumor Biology Effects of intravenous zoledronic acid and oral ibandronate on early changes in markers of bone turnover in patients with bone metastases from non-small cell lung cancer, International Journal of Clinical Oncology Update on the Use of Zoledronic Acid in the Management of Osteoporosis, Current Osteoporosis Reports Antiproliferative Efficacy of the Third-Generation Bisphosphonate, Zoledronic Acid, Combined with Other Anticancer Drugs in Leukemic Cell Lines, International Journal of Hematology Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats, Osteoporosis International